Moshe Leshno

Medicine & Life Sciences

1. Cost-Benefit Analysis 100%
2. Decision Support Techniques 96%
3. Israel 67%
4. Quality-Adjusted Life Years 63%
5. Costs and Cost Analysis 54%
6. Electronic Health Records 49%
7. Population 42%
8. Clinical Decision-Making 41%
9. Physicians 35%
10. Hospital Emergency Service 34%
11. Decision Making 28%
12. Chronic Hepatitis C 28%
13. Hepacivirus 26%
14. Milk Hypersensitivity 26%
15. Celiac Disease 24%
16. Occult Blood 24%
17. Milk Proteins 24%
18. Colorectal Neoplasms 24%
19. Survival 23%
20. Colonoscopy 23%
21. Health Information Exchange 23%
22. Adenoma 22%
23. Milk 22%
24. Gastroesophageal Reflux 21%
25. Economics 21%
26. Fatty Liver 21%
27. Liver Transplantation 21%
28. Hepatitis C 20%
29. Therapeutics 20%
30. Hematologic Tests 20%
31. Mortality 20%
32. pembrolizumab 19%
33. Neoplasms 19%
34. Immunoglobulin E 19%
35. Nivolumab 19%
36. Trial of Labor 19%
37. Fibrosis 19%
38. Placebos 18%
39. Liver Cirrhosis 18%
40. Meta-Analysis 17%
41. Delivery of Health Care 17%
42. Child 17%
43. Decision Trees 17%
44. Quality of Life 15%
45. Dyspepsia 15%
46. Neck Dissection 15%
47. Food Hypersensitivity 15%
48. Information Systems 15%
49. Postoperative Care 15%
50. Papillary Thyroid Cancer 14%